AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2023
May 5, 2023
35119_dirs_2023-05-05_179d0175-5e57-4c31-bdbe-2c2df983027c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2023-05-03
Reporting Person: Cote Timothy R. (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-03 | Stock Option (Right to Buy) | $1.42 | A | 15000 | Acquired | 2033-05-02 | COMMON STOCK (15000) | Direct |
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3